Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glial Tumor of Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00003176
What this trial is testing

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 82
Early research (Phase 1)Study completedNCT01273090
What this trial is testing

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+2 more
Children's Oncology Group 34
Early research (Phase 1)Study completedNCT01654497
What this trial is testing

Dexanabinol in Patients With Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari, M.D., Ph.D. 26
Early research (Phase 1)Looking for participantsNCT05106296
What this trial is testing

Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer

Who this might be right for
EpendymomaMedulloblastomaGlioblastoma+1 more
Theodore S. Johnson 37
Early research (Phase 1)Looking for participantsNCT07733674
What this trial is testing

Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
Radiomedix, Inc. 20
Early research (Phase 1)Study completedNCT00006025
What this trial is testing

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)UnknownNCT00591058
What this trial is testing

Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 36
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Early research (Phase 1)Study completedNCT01234740
What this trial is testing

Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+7 more
City of Hope Medical Center 7
Large-scale testing (Phase 3)UnknownNCT00256425
What this trial is testing

Cognitive Rehabilitation of Glioma Patients

Who this might be right for
GliomaCognition Disorders
UMC Utrecht 140
Testing effectiveness (Phase 2)Study completedNCT00540176
What this trial is testing

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

Who this might be right for
Malignant Gliomas, Glioblastoma Multiforme
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT01339052
What this trial is testing

Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
L. Nicolas Gonzalez Castro, MD, PhD 65
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT02861898
What this trial is testing

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain CancerBrain Neoplasm+4 more
Northwell Health 33
Early research (Phase 1)Active Not RecruitingNCT04837547
What this trial is testing

PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy

Who this might be right for
NeuroblastomaDiffuse Intrinsic Pontine Glioma
University of Florida 24
Not applicableStudy completedNCT03551249
What this trial is testing

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption

Who this might be right for
GliomaGlioblastoma
InSightec 20
Testing effectiveness (Phase 2)Study completedNCT00003185
What this trial is testing

Biological Therapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
The Cleveland Clinic 40
Testing effectiveness (Phase 2)Ended earlyNCT00548938
What this trial is testing

Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM

Who this might be right for
Glioblastoma MultiformeHigh-Grade Glioma
Methodist Healthcare - Memphis 40
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Not applicableLooking for participantsNCT07413796
What this trial is testing

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Who this might be right for
Brain Tumor AdultBrain Tumor BenignMeningioma+2 more
Medical University of Warsaw 382
Next Page